Last Updated On 26 April 2019 2 Min Read
Shareholders push for new directors at debt-laden Ascendis
Two investors for the pharmaceutical group want a general meeting to address issues and make executive changes
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In